Vizora日本語

Oncolys BioPharmaOncolys BioPharma Inc.4588東証グロース医薬品FY ending Dec 2025, non-consolidated, J-GAAP

Oncolys BioPharma FY ending Dec 2020 results

About 100% of Oncolys BioPharma's sales come from Pharmaceutical Division, with Diagnostic Division making up much of the rest.

It lost about ¥533 for every ¥100 of sales at the operating level.

Revenue changed -75.9% from the prior year.

What changed from last year

FY ending Dec 2019 → FY ending Dec 2020

Revenue
-75.9%¥1.3B → ¥314.2M
Gross profit
-80.2%¥1.19B → ¥236.1M
Operating income
Loss-¥511.5M → -¥1.67B
Operating cash flow
Loss-¥238.2M → -¥1.47B
Free cash flow
Loss-¥242.5M → -¥1.47B

Where the money goes

FY ending Dec 2019 → FY ending Dec 2020

Where ¥100 of sales goes

For every ¥100 Oncolys BioPharma sells, how much goes where, and how much is kept.

FY ending Dec 2020
Cost of sales
¥25
SG&A
¥608
Operating loss
¥533
Net loss
¥667

Annual margin trends

Gross margin75.2%
FY ending Dec 2019: 91.3%91.3%FY ending Dec 2020: 75.2%75.2%FY19FY20
Operating margin-533.0%
FY ending Dec 2019: -39.2%-39.2%FY ending Dec 2020: -533.0%-533.0%FY19FY20
Net margin-666.8%
FY ending Dec 2019: -70.0%-70.0%FY ending Dec 2020: -666.8%-666.8%FY19FY20

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Dec 2020
  • Pharmaceutical Division¥313.6M
    100%
    Op. margin -227.5%
  • Diagnostic Division¥610K
    0%
    Op. margin -12023.9%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (5)

  • EDINET (FSA Japan)

    有価証券報告書－第21期(2024/01/01－2024/12/31)

    ID S100VIBY2025-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第20期(2023/01/01－2023/12/31)

    ID S100T65H2024-03-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(2022/01/01－2022/12/31)

    ID S100QI262023-03-30Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第18期(令和3年1月1日－令和3年12月31日)

    ID S100PNC22022-11-17Open

  • EDINET (FSA Japan)

    有価証券報告書－第17期(令和2年1月1日－令和2年12月31日)

    ID S100L1LQ2021-03-26Open

Extracted from XBRL: 43 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image